rs2548541

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004385.5(VCAN):​c.4323G>A​(p.Gln1441Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.623 in 1,613,732 control chromosomes in the GnomAD database, including 315,623 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 35430 hom., cov: 32)
Exomes 𝑓: 0.62 ( 280193 hom. )

Consequence

VCAN
NM_004385.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.634

Publications

22 publications found
Variant links:
Genes affected
VCAN (HGNC:2464): (versican) This gene is a member of the aggrecan/versican proteoglycan family. The protein encoded is a large chondroitin sulfate proteoglycan and is a major component of the extracellular matrix. This protein is involved in cell adhesion, proliferation, proliferation, migration and angiogenesis and plays a central role in tissue morphogenesis and maintenance. Mutations in this gene are the cause of Wagner syndrome type 1. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2009]
VCAN-AS1 (HGNC:40163): (VCAN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 5-83537326-G-A is Benign according to our data. Variant chr5-83537326-G-A is described in ClinVar as Benign. ClinVar VariationId is 198803.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.634 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.798 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VCANNM_004385.5 linkc.4323G>A p.Gln1441Gln synonymous_variant Exon 8 of 15 ENST00000265077.8 NP_004376.2 P13611-1A0A024RAQ9Q59FG9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VCANENST00000265077.8 linkc.4323G>A p.Gln1441Gln synonymous_variant Exon 8 of 15 1 NM_004385.5 ENSP00000265077.3 P13611-1

Frequencies

GnomAD3 genomes
AF:
0.677
AC:
102774
AN:
151908
Hom.:
35382
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.805
Gnomad AMI
AF:
0.720
Gnomad AMR
AF:
0.623
Gnomad ASJ
AF:
0.712
Gnomad EAS
AF:
0.635
Gnomad SAS
AF:
0.720
Gnomad FIN
AF:
0.669
Gnomad MID
AF:
0.693
Gnomad NFE
AF:
0.609
Gnomad OTH
AF:
0.698
GnomAD2 exomes
AF:
0.643
AC:
161062
AN:
250626
AF XY:
0.644
show subpopulations
Gnomad AFR exome
AF:
0.808
Gnomad AMR exome
AF:
0.589
Gnomad ASJ exome
AF:
0.715
Gnomad EAS exome
AF:
0.629
Gnomad FIN exome
AF:
0.654
Gnomad NFE exome
AF:
0.613
Gnomad OTH exome
AF:
0.638
GnomAD4 exome
AF:
0.617
AC:
902380
AN:
1461702
Hom.:
280193
Cov.:
87
AF XY:
0.620
AC XY:
450726
AN XY:
727148
show subpopulations
African (AFR)
AF:
0.813
AC:
27196
AN:
33466
American (AMR)
AF:
0.594
AC:
26521
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.711
AC:
18570
AN:
26130
East Asian (EAS)
AF:
0.658
AC:
26127
AN:
39696
South Asian (SAS)
AF:
0.702
AC:
60573
AN:
86258
European-Finnish (FIN)
AF:
0.648
AC:
34601
AN:
53402
Middle Eastern (MID)
AF:
0.699
AC:
4030
AN:
5768
European-Non Finnish (NFE)
AF:
0.599
AC:
666428
AN:
1111924
Other (OTH)
AF:
0.635
AC:
38334
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
25055
50111
75166
100222
125277
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18220
36440
54660
72880
91100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.677
AC:
102877
AN:
152030
Hom.:
35430
Cov.:
32
AF XY:
0.681
AC XY:
50569
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.805
AC:
33410
AN:
41492
American (AMR)
AF:
0.623
AC:
9506
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.712
AC:
2468
AN:
3466
East Asian (EAS)
AF:
0.635
AC:
3274
AN:
5156
South Asian (SAS)
AF:
0.719
AC:
3462
AN:
4818
European-Finnish (FIN)
AF:
0.669
AC:
7066
AN:
10568
Middle Eastern (MID)
AF:
0.701
AC:
206
AN:
294
European-Non Finnish (NFE)
AF:
0.609
AC:
41355
AN:
67958
Other (OTH)
AF:
0.698
AC:
1473
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1642
3285
4927
6570
8212
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
806
1612
2418
3224
4030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.636
Hom.:
51514
Bravo
AF:
0.674
Asia WGS
AF:
0.663
AC:
2303
AN:
3478
EpiCase
AF:
0.622
EpiControl
AF:
0.623

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Wagner syndrome Benign:3
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 08, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Vitreoretinopathy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.14
DANN
Benign
0.81
PhyloP100
-0.63
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2548541; hg19: chr5-82833145; COSMIC: COSV54100085; COSMIC: COSV54100085; API